Surmodics EBITDA Margin 2010-2024 | SRDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surmodics (SRDX) over the last 10 years. The current EBITDA margin for Surmodics as of June 30, 2024 is .
| Surmodics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $0.12B | $0.00B | 1.65% |
| 2024-03-31 | $0.14B | $0.03B | 20.28% |
| 2023-12-31 | $0.14B | $0.02B | 15.94% |
| 2023-09-30 | $0.13B | $0.02B | 11.36% |
| 2023-06-30 | $0.13B | $0.01B | 8.46% |
| 2023-03-31 | $0.10B | $-0.02B | -17.48% |
| 2022-12-31 | $0.10B | $-0.02B | -16.67% |
| 2022-09-30 | $0.10B | $-0.01B | -13.00% |
| 2022-06-30 | $0.10B | $-0.01B | -7.14% |
| 2022-03-31 | $0.10B | $-0.00B | -3.09% |
| 2021-12-31 | $0.11B | $0.01B | 10.38% |
| 2021-09-30 | $0.11B | $0.01B | 13.33% |
| 2021-06-30 | $0.10B | $0.01B | 11.54% |
| 2021-03-31 | $0.11B | $0.02B | 14.95% |
| 2020-12-31 | $0.10B | $0.01B | 7.37% |
| 2020-09-30 | $0.10B | $0.01B | 7.29% |
| 2020-06-30 | $0.10B | $0.01B | 12.50% |
| 2020-03-31 | $0.10B | $0.01B | 12.87% |
| 2019-12-31 | $0.10B | $0.01B | 13.86% |
| 2019-09-30 | $0.10B | $0.01B | 14.00% |
| 2019-06-30 | $0.09B | $0.01B | 7.61% |
| 2019-03-31 | $0.09B | $-0.00B | -1.11% |
| 2018-12-31 | $0.09B | $-0.00B | -2.33% |
| 2018-09-30 | $0.08B | $-0.00B | -3.70% |
| 2018-06-30 | $0.08B | 0 | 0.00% |
| 2018-03-31 | $0.07B | $0.01B | 10.81% |
| 2017-12-31 | $0.07B | $0.01B | 12.33% |
| 2017-09-30 | $0.07B | $0.01B | 17.57% |
| 2017-06-30 | $0.07B | $0.02B | 22.22% |
| 2017-03-31 | $0.07B | $0.02B | 28.38% |
| 2016-12-31 | $0.07B | $0.02B | 30.14% |
| 2016-09-30 | $0.07B | $0.02B | 30.56% |
| 2016-06-30 | $0.07B | $0.02B | 30.99% |
| 2016-03-31 | $0.07B | $0.02B | 31.34% |
| 2015-12-31 | $0.06B | $0.02B | 34.38% |
| 2015-09-30 | $0.06B | $0.02B | 37.70% |
| 2015-06-30 | $0.06B | $0.02B | 40.68% |
| 2015-03-31 | $0.06B | $0.02B | 39.66% |
| 2014-12-31 | $0.06B | $0.02B | 37.93% |
| 2014-09-30 | $0.06B | $0.02B | 36.21% |
| 2014-06-30 | $0.06B | $0.02B | 36.84% |
| 2014-03-31 | $0.06B | $0.02B | 35.71% |
| 2013-12-31 | $0.06B | $0.02B | 37.50% |
| 2013-09-30 | $0.06B | $0.02B | 39.29% |
| 2013-06-30 | $0.06B | $0.02B | 37.50% |
| 2013-03-31 | $0.06B | $0.02B | 39.29% |
| 2012-12-31 | $0.05B | $0.02B | 38.89% |
| 2012-09-30 | $0.05B | $0.02B | 36.54% |
| 2012-06-30 | $0.05B | $0.02B | 34.62% |
| 2012-03-31 | $0.05B | $0.02B | 33.33% |
| 2011-12-31 | $0.05B | $0.02B | 34.62% |
| 2011-09-30 | $0.05B | $0.02B | 35.85% |
| 2011-06-30 | $0.06B | $-0.00B | -9.09% |
| 2011-03-31 | $0.06B | $-0.01B | -9.84% |
| 2010-12-31 | $0.07B | $-0.01B | -15.15% |
| 2010-09-30 | $0.07B | $-0.01B | -14.29% |
| 2010-06-30 | $0.07B | $0.02B | 21.92% |
| 2010-03-31 | $0.07B | $0.02B | 25.00% |
| 2009-12-31 | $0.08B | $0.03B | 33.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.562B | $0.133B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.609B | 25.65 |
| Stryker (SYK) | United States | $139.112B | 32.51 |
| Boston Scientific (BSX) | United States | $123.274B | 37.54 |
| Medtronic (MDT) | Ireland | $114.744B | 17.07 |
| EssilorLuxottica (ESLOY) | France | $106.116B | 0.00 |
| Haleon (HLN) | United Kingdom | $47.707B | 34.87 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.203B | 0.00 |
| ResMed (RMD) | United States | $35.702B | 31.43 |
| Koninklijke Philips (PHG) | Netherlands | $29.054B | 22.08 |
| Terumo (TRUMY) | Japan | $28.562B | 40.34 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.656B | 13.63 |
| Baxter (BAX) | United States | $19.774B | 13.41 |
| Insulet (PODD) | United States | $16.665B | 70.11 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.531B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.604B | 31.82 |
| Demant (WILYY) | Denmark | $9.197B | 0.00 |
| BellRing Brands (BRBR) | United States | $7.682B | 32.48 |
| Lantheus Holdings (LNTH) | United States | $7.537B | 18.09 |
| ICU Medical (ICUI) | United States | $4.428B | 42.25 |
| TG Therapeutics (TGTX) | United States | $3.914B | 41.44 |
| Haemonetics (HAE) | United States | $3.842B | 19.01 |
| Neogen (NEOG) | United States | $3.799B | 39.84 |
| Perrigo (PRGO) | Ireland | $3.788B | 11.97 |
| GN Store Nord (GNNDY) | Denmark | $3.691B | 22.23 |
| Prestige Consumer Healthcare (PBH) | United States | $3.663B | 18.25 |
| Envista Holdings (NVST) | United States | $3.324B | 17.73 |
| QuidelOrtho (QDEL) | United States | $3.108B | 19.59 |
| Agios Pharmaceuticals (AGIO) | United States | $2.696B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.230B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.192B | 36.79 |
| LeMaitre Vascular (LMAT) | United States | $2.026B | 54.00 |
| AdaptHealth (AHCO) | United States | $1.520B | 10.97 |
| InMode (INMD) | Israel | $1.490B | 9.49 |
| Warby Parker (WRBY) | United States | $1.483B | 0.00 |
| AtriCure (ATRC) | United States | $1.403B | 0.00 |
| Owens & Minor (OMI) | United States | $1.237B | 9.55 |
| BioLife Solutions (BLFS) | United States | $1.187B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.110B | 0.00 |
| Evolus (EOLS) | United States | $1.037B | 0.00 |
| PetIQ (PETQ) | United States | $0.919B | 23.30 |
| Phibro Animal Health (PAHC) | United States | $0.908B | 18.83 |
| National Vision Holdings (EYE) | United States | $0.862B | 27.40 |
| Cresco Labs (CRLBF) | United States | $0.805B | 0.00 |
| Quanterix (QTRX) | United States | $0.594B | 0.00 |
| ZimVie (ZIMV) | United States | $0.468B | 43.49 |
| VAREX IMAGING (VREX) | United States | $0.445B | 13.43 |
| Valneva SE (VALN) | France | $0.419B | 0.00 |
| Jin Medical (ZJYL) | China | $0.411B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.401B | 0.00 |
| Cerus (CERS) | United States | $0.339B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.335B | 0.00 |
| Biote (BTMD) | United States | $0.331B | 15.27 |
| OraSure Technologies (OSUR) | United States | $0.324B | 8.37 |
| Aurora Cannabis (ACB) | Canada | $0.315B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.290B | 31.08 |
| Zynex (ZYXI) | United States | $0.264B | 46.28 |
| Utah Medical Products (UTMD) | United States | $0.236B | 15.70 |
| Omeros (OMER) | United States | $0.234B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.221B | 0.00 |
| MacroGenics (MGNX) | United States | $0.213B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.172B | 71.33 |
| Capricor Therapeutics (CAPR) | United States | $0.162B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 20.74 |
| Brainsway (BWAY) | Israel | $0.137B | 163.80 |
| TriSalus Life Sciences (TLSI) | United States | $0.135B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.129B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.122B | 0.00 |
| Veru (VERU) | United States | $0.117B | 0.00 |
| Fonar (FONR) | United States | $0.110B | 11.15 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 24.70 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.087B | 0.00 |
| InterCure (INCR) | Israel | $0.085B | 14.31 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| Safety Shot (SHOT) | United States | $0.076B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.076B | 0.00 |
| Modular Medical (MODD) | United States | $0.074B | 0.00 |
| MariMed (MRMD) | United States | $0.065B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.055B | 3.62 |
| Exagen (XGN) | United States | $0.050B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.041B | 0.00 |
| Apyx Medical (APYX) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.026B | 0.00 |
| Nephros (NEPH) | United States | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.016B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.016B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.007B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.000B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 20.48 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |